Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, and a recruitment status note indicates no longer looking for participants. The Interventions header has been standardized to Intervention/Treatment, and the revision tag has been updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T05:11:20.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.5.4 to v3.5.5, indicating a minor version update to the page's documentation rather than a substantive change to the study content. This update does not modify any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-05T21:41:09.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.5.3 to v3.5.4. This reflects a minor site revision without altering the displayed content.
    Difference
    0.1%
    Check dated 2026-05-15T14:45:53.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A Publications subsection was added to the Study Record, listing the article 'Immunotherapy in B-Cell Acute Lymphoblastic Leukemia' by Davis KL et al. with DOI 10.6004/jnccn.2025.7067, and noting that publications are automatically filled from PubMed.
    Difference
    0.3%
    Check dated 2026-05-08T11:44:06.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a site/application version change without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:27:55.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:48:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.